Discovery of transcriptional signature of glucocorticoid receptor (GR) activation in ovarian cancer using selective GR modulators

      Objective: To identify transcriptional targets of glucocorticoid receptor (GR) involved in modulating ovarian cancer chemotherapy response and risk of recurrence.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect